RECOMBINATE 500 IU
Nchi: Israeli
Lugha: Kiingereza
Chanzo: Ministry of Health
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
COAGULATION FACTOR VIII RECOMBINANT 500 IU/VIAL
Inapatikana kutoka:
TEVA MEDICAL MARKETING LTD.
ATC kanuni:
B02BD05
Dawa fomu:
POWDER FOR SOLUTION FOR INJECTION
Njia ya uendeshaji:
I.V
Viwandani na:
BAXTER S.A., BELGIUM
Kundi la matibabu:
COAGULATION FACTOR VII
Matibabu dalili:
The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.
Idhini ya tarehe:
2010-07-01
